Fig. 6.
Fig. 6. Piceatannol inhibition of protein tyrosine phosphorylation in platelets. Human platelets were pretreated with DMSO or piceatannol (40 μg/mL) for 10 minutes at room temperature before the addition of PBS (−), 0.1 U/mL thrombin, or 0.1 U/mL thrombin plus stirring. After 2 minutes, the platelets were solubilized in RIPA buffer and the proteins were separated by SDS-PAGE on an 8% gel and transferred to nitrocellulose. (A) Total protein lysates. (B) FAK immunoprecipitated from platelet lysates. In each case the blots were probed with the antiphosphotyrosine antibodies 4G10 and PY-20. (B) The blot stripped and reprobed with the anti-FAK antibody to confirm equal loading of protein. Proteins were visualized using ECL detection methods. The molecular weight standards are indicated to the left.

Piceatannol inhibition of protein tyrosine phosphorylation in platelets. Human platelets were pretreated with DMSO or piceatannol (40 μg/mL) for 10 minutes at room temperature before the addition of PBS (−), 0.1 U/mL thrombin, or 0.1 U/mL thrombin plus stirring. After 2 minutes, the platelets were solubilized in RIPA buffer and the proteins were separated by SDS-PAGE on an 8% gel and transferred to nitrocellulose. (A) Total protein lysates. (B) FAK immunoprecipitated from platelet lysates. In each case the blots were probed with the antiphosphotyrosine antibodies 4G10 and PY-20. (B) The blot stripped and reprobed with the anti-FAK antibody to confirm equal loading of protein. Proteins were visualized using ECL detection methods. The molecular weight standards are indicated to the left.

Close Modal

or Create an Account

Close Modal
Close Modal